First anthrax vaccine developed using recombinant DNA technology- Annual production capacity of up to 10 million doses at GC ...

An Australian biotech firm says it has successfully used precision fermentation to reproduce the most vital proteins in human ...

Everon Healthcare is a distinguished Chinese company focused on the research, development and industrialization of recombinant triple-helical collagen.

According to Research by SNS Insider, the U.S. Peptide Therapeutics Market is Set to Reach USD 35.71 Billion by 2032, Supported by Rising Adoption of Precision Biologics and Advances in Peptide ...

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, today announced that it has been granted usage rights to a significant block of ...

The global market for Human Vaccines was valued at US$46.9 Billion in 2024 and is projected to reach US$71.4 Billion by 2030, growing at a CAGR of 7.3% from 2024 to 2030. This comprehensive report ...

A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...

The protein, reverse transcriptase, has become an essential tool for making DNA copies of RNA.

Novavax, Inc. (NASDAQ: NVAX) ranks among the most oversold biotech stocks to invest in. Novavax, Inc. (NASDAQ:NVAX) announced ...

Recombinant human TSH (rhTSH) is used in patients who have had surgery for thyroid cancer but are at low risk of recurrence. The rhTSH is used for the preparation of postoperative administration of ...

The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has opined that ...

University of Arkansas System President Jay B. Silveria has named four finalists to be the next University of Arkansas for ...